Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telcyta plus Liposomal Doxorubicin in platinum-resistant ovarian cancer
NCT00350948Phase 3Terminated
- Sponsor
- Telik, Inc.
- Start
- May 2006
- Primary completion
- Dec 2008
- Countries
- 4
01
Overview
A Phase 3 trial of canfosfamide in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Telik, Inc.. Started May 2006; status: terminated.
02
Drugs
canfosfamide
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00350948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350948.